/
/
/

Alembic Pharmaceuticals Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)808.00
Volume (₹)35,501.00
High (₹)830.00
Upper Circuit963.35
Low (₹)803.65
Lower Circuit642.25
Prev Close802.80
52W High (₹)998.00
Price825.55
52W Low (₹)635.80

Share Market Cap & Key Ratios Overview

M.Cap (₹)15807.60 Cr
Div. Yield (%)1.49
PE Ratio22.80
Debt to Equity0.24
Price to Book2.29
Book Value288.72
EPS (TTM)35.28
Face Value2.00
ROE (%)12.35

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
APLLTDNSE
LTP
1W Low
1W High
Market cap (₹)
1799+21.3 (1.20%)
1722
1810.40
4,25,150Cr
9990+210 (2.15%)
9863
10067
2,66,265Cr
4673.1+59.7 (1.29%)
4553
4685.60
1,76,301Cr
2329.2-76.3 (-3.17%)
2252.40
2441.90
1,25,352Cr
1257.9+12.4 (1.00%)
1217.20
1264.50
1,23,591Cr
1366.6+14.6 (1.08%)
1336.70
1376.70
1,14,351Cr
1396.5+17.6 (1.28%)
1364.60
1400.80
1,12,474Cr
2496.8+4 (0.16%)
2457.90
2512.30
1,02,315Cr
1702.2+20.8 (1.24%)
1656.20
1708.80
97,757Cr
2037.8+26.8 (1.33%)
1988.90
2062.10
92,007Cr
825.55+27.7 (3.47%)
786.50
830
15,808Cr

Key Highlights of Alembic Pharmaceuticals Ltd Balance Sheet

Alembic Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹39.31Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹39.31Cr, and the reserves and surplus of the company is ₹5575.95Cr.

The company has its non-current liabilities with total liabilities of ₹8040.45Cr as of 2026-03-31.

The current liabilities are ₹2425.02Cr as of 2026-03-31. At the same time, current assets are ₹4069.87Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹271.4Cr and tangible assets of ₹2828.42Cr, provided in the Alembic Pharmaceuticals Ltd financial statements.